The study involved two patients with recurrent GBM who underwent serial biopsies over four months of CAN-3110 treatment. Not only was the procedure well tolerated in these patients, but it also ...
A new study led by Break Through Cancer's Accelerating Glioblastoma (GBM) Therapies Through Serial Biopsies TeamLab has revealed that an engineered virus therapy, CAN-3110, triggered powerful immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback